Easy, Accurate and Affordable Cancer Screening....Welcome to the Beacon Revolution!
Beacon Biomedical is focused on the early detection of breast, colorectal and lung cancers for three reasons. First, these are the three most frequently diagnosed forms of cancer accounting for more than 1/3 of all cancer cases in the US. Second, there are among the deadliest forms of cancer responsible for nearly 1/2 of all cancer deaths. Lastly, we focus on these cancer because in each case, early detection has been proven to save lives, but only when patients get screened.
About Breast Cancer
According to the World Health Organization (WHO), breast cancer is the second most commonly diagnosed cancer world-wide. Globally, an estimated 522,000 women die from breast cancer annually. In the U.S., breast cancer is the second leading cause of cancer deaths in women with 40,000 women dying each year. The lifetime risk for women in the U.S. of developing breast cancer is 1-in-8.
About Colorectal Cancer
According to WHO, colorectal cancer is the third most commonly diagnosed cancer world-wide. Globally, an estimated 700,000 individuals die from colorectal cancer annually. In the U.S., colorectal cancer is the third leading cause of death in men and women with 59,000 individuals dying each year. The lifetime risk of developing colorectal cancer is the U.S. is 1-in-20.
About Lung Cancer
According to WHO, lung cancer is the most commonly diagnosed cancer world-wide. Globally, an estimated 1.59 million individuals die from lung cancer annually. In the U.S., lung cancer is the number one cause of deaths in men and women with an estimated 154,000 individuals dying each year.
Future Portfolio Tests for Cancer Screening Include Ovarian and Prostate Cancers.
In the U.S., the 1/3rd of the women who are noncompliant with recommended early breast cancer screening test and procedures account for 72% of all breast cancer deaths.
In the U.S., the 1/3rd of the men and women who are noncompliant with recommended early colorectal cancer screening tests and procedures account for 60% of all colorectal cancer deaths.
In the U.S., 90% of all lung cancer deaths can be attributed to long-term smokers or ex-smokers of cigarettes. It is the most common cause of cancer deaths world-wide estimated to be responsible for 1-in-5 of all cancer deaths. The lack of easy to administer, accessible and affordable early detection test and procedures is manifested by the high mortality and extremely low survivability rate (av. 16.8% 5-yr.) for this disease.